Furthermore, it can suppress CRC tumorigenesis through promoting the proteasomal degradation of euchromatic histone-lysine N-methyltransferase 2 (EHMT2) through HECT domain E3 ubiquitin protein ligase 2 (HECTD2) up-regulation [257]. The gene discussed is EHMT2; the disease is colorectal carcinoma.